Sign up to save your podcasts
Or
Share Biosimilars in Multiple Sclerosis: Entering a New Era of Biologic Therapy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Biosimilars in Multiple Sclerosis: Entering a New Era of Biologic Therapy
Did you know what the inherent variability of all biologics and what degree of variation are acceptable by regulatory bodies?
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989395?src=mkm_podcast_addon_989395
View all episodes
By Medscape Podcasts
4
77 ratings
Did you know what the inherent variability of all biologics and what degree of variation are acceptable by regulatory bodies?
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989395?src=mkm_podcast_addon_989395
More shows like Keeping Current
View all
JAMA Editors' Summary
137 Listeners
NEJM This Week
319 Listeners
JAMA Clinical Reviews
498 Listeners
Diabetes Core Update
102 Listeners
This Week in Cardiology
882 Listeners
The Bob Harrington Show
13 Listeners
One-on-One with Eric Topol
17 Listeners
Mayo Clinic Talks
289 Listeners
The Curbsiders Internal Medicine Podcast
3,339 Listeners
Core IM | Internal Medicine Podcast
1,151 Listeners
Annals On Call Podcast
191 Listeners
JAMA Medical News
88 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Medicine and the Machine
61 Listeners
Keeping Current CME
26 Listeners
Cardionerds: A Cardiology Podcast
431 Listeners
The Curious Clinicians
372 Listeners